Genes, environment and the value of prospective cohort studies
暂无分享,去创建一个
Francis S. Collins | Teri A. Manolio | Joan E. Bailey-Wilson | F. Collins | T. Manolio | J. Bailey-Wilson
[1] J K McLaughlin,et al. Selection of controls in case-control studies. III. Design options. , 1992, American journal of epidemiology.
[2] J. Manson,et al. The Nurses' Health Study: 20-year contribution to the understanding of health among women. , 1997, Journal of women's health.
[3] J. Després,et al. Visceral obesity attenuates the effect of the hepatic lipase -514C>T polymorphism on plasma HDL-cholesterol levels in French-Canadian men. , 2003, Molecular genetics and metabolism.
[4] Birgir Hrafnkelsson,et al. An Icelandic example of the impact of population structure on association studies , 2005, Nature Genetics.
[5] R. Ward,et al. Informativeness of genetic markers for inference of ancestry. , 2003, American journal of human genetics.
[6] A Taube,et al. Matching in retrospective studies; sampling via the dependent variable. , 1968, Acta Societatis Medicorum Upsaliensis.
[7] JoAnn E. Manson,et al. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.
[8] D. Sackett. Bias in analytic research. , 1979, Journal of chronic diseases.
[9] N. Kouprina,et al. Separation of long-range human TERT gene haplotypes by transformation-associated recombination cloning in yeast , 2003, Oncogene.
[10] Z. L. Monaco,et al. Artificial and engineered chromosomes: developments and prospects for gene therapy , 2005, Chromosoma.
[11] Joydeep Basu,et al. Efficient assembly of de novo human artificial chromosomes from large genomic loci , 2005, BMC Biotechnology.
[12] Simon Watkins,et al. Personalized Exposure Assessment: Promising Approaches for Human Environmental Health Research , 2005, Environmental health perspectives.
[13] Raj Chari,et al. Recent advances in array comparative genomic hybridization technologies and their applications in human genetics , 2006, European Journal of Human Genetics.
[14] Enrique Sanchez-Delgado,et al. Lifetime risk of developing coronary heart disease , 1999, The Lancet.
[15] Aravinda Chakravarti,et al. Nature, nurture and human disease , 2003, Nature.
[16] Eric S. Lander,et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes , 2000, Nature Genetics.
[17] M. Olivier. A haplotype map of the human genome. , 2003, Nature.
[18] Joydeep Basu,et al. Artificial and engineered chromosomes: non-integrating vectors for gene therapy. , 2005, Trends in molecular medicine.
[19] R. Triendl. Japan launches controversial Biobank project , 2003, Nature Medicine.
[20] E Riboli,et al. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. , 1997, International journal of epidemiology.
[21] R. Doll. Proof of Causality: Deduction from Epidemiological Observation , 2002, Perspectives in biology and medicine.
[22] W. Kannel,et al. The Framingham Study: ITS 50-year legacy and future promise. , 2000, Journal of atherosclerosis and thrombosis.
[23] D. Hunter. Gene–environment interactions in human diseases , 2005, Nature Reviews Genetics.
[24] W James Gauderman,et al. Sample size requirements for matched case‐control studies of gene–environment interaction , 2002, Statistics in medicine.
[25] H. Austin,et al. Limitations in the application of case-control methodology. , 1994, Epidemiologic reviews.
[26] Will Investments in Large-Scale Prospective Cohorts and Biobanks Limit Our Ability to Discover Weaker, Less Common Genetic and Environmental Contributors to Complex Diseases? , 2004, Environmental health perspectives.
[27] P. Wilson,et al. Dietary Fat Intake Determines the Effect of a Common Polymorphism in the Hepatic Lipase Gene Promoter on High-Density Lipoprotein Metabolism: Evidence of a Strong Dose Effect in This Gene-Nutrient Interaction in the Framingham Study , 2002, Circulation.
[28] A R Feinstein,et al. The case-control study: valid selection of subjects. , 1985, Journal of chronic diseases.
[29] H. Stefánsson,et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.
[30] Jinbo Chen,et al. Genetic Variation and Willingness to Participate in Epidemiologic Research: Data from Three Studies , 2005, Cancer Epidemiology Biomarkers & Prevention.
[31] S. Studenski,et al. Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. , 2006, JAMA.
[32] T. Manolio. Novel risk markers and clinical practice. , 2003, The New England journal of medicine.
[33] J. Neyman. Statistics—Servant of All Science , 1955 .
[34] D O Stram,et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. , 2000, American journal of epidemiology.
[35] N. Mantel. Synthetic retrospective studies and related topics. , 1973, Biometrics.
[36] W. Earnshaw,et al. Efficiency of de novo centromere formation in human artificial chromosomes. , 2002, Genomics.
[37] David Clayton,et al. Epidemiological methods for studying genes and environmental factors in complex diseases , 2001, The Lancet.
[38] J. Ellenberg,et al. Sample selection and the natural history of disease. Studies of febrile seizures. , 1980, JAMA.
[39] Muin J Khoury,et al. The case for a global human genome epidemiology initiative , 2004, Nature Genetics.
[40] H. Willard,et al. Alpha-satellite DNA and vector composition influence rates of human artificial chromosome formation. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[41] A. Folsom,et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). , 2002, The American journal of medicine.
[42] Evan E. Eichler,et al. An assessment of the sequence gaps: Unfinished business in a finished human genome , 2004, Nature Reviews Genetics.
[43] J. Lupski,et al. Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. , 2004, Human molecular genetics.
[44] J. Stamler. Blood pressure and high blood pressure. Aspects of risk. , 1991, Hypertension.
[45] Terrence S. Furey,et al. The DNA sequence and biology of human chromosome 19 , 2004, Nature.
[46] L. Hsu,et al. The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density-lipoprotein cholesterol levels in Taiwanese-Chinese. , 2004, Atherosclerosis.
[47] M. Olivier. A haplotype map of the human genome , 2003, Nature.
[48] J K McLaughlin,et al. Selection of controls in case-control studies. I. Principles. , 1992, American journal of epidemiology.
[49] S. Naylor,et al. Promise and Challenge: Markers of Prostate Cancer Detection, Diagnosis and Prognosis , 2004, Disease markers.
[50] T. Okazaki,et al. Generation of human artificial chromosomes expressing naturally controlled guanosine triphosphate cyclohydrolase I gene , 2002, Genes to cells : devoted to molecular & cellular mechanisms.
[51] E. Marshall. Whose DNA Is It, Anyway? , 1997, Science.
[52] M. Khoury,et al. Public Attitudes regarding the Donation and Storage of Blood Specimens for Genetic Research , 2001, Public Health Genomics.
[53] E. Eichler,et al. Segmental duplications and copy-number variation in the human genome. , 2005, American journal of human genetics.
[54] E. Feskens,et al. Interactions of dietary fat intake and the hepatic lipase -480C-->T polymorphism in determining hepatic lipase activity: the Hoorn Study. , 2005, The American journal of clinical nutrition.
[55] R. Prentice,et al. On the design of synthetic case-control studies. , 1986, Biometrics.
[56] E. Thomson,et al. The Ethical, Legal, and Social Implications Research Program at the National Human Genome Research Institute , 1997, Kennedy Institute of Ethics journal.
[57] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[58] L. Feuk,et al. Structural variants: changing the landscape of chromosomes and design of disease studies. , 2006, Human molecular genetics.
[59] Francis S. Collins,et al. The case for a US prospective cohort study of genes and environment , 2004, Nature.
[60] W. Kannel,et al. Clinical misconceptions dispelled by epidemiological research. , 1995, Circulation.
[61] Y. Ben-Shlomo,et al. Magnitude and causes of mortality differences between married and unmarried men. , 1993, Journal of epidemiology and community health.
[62] Virginia Barbour,et al. UK Biobank: a project in search of a protocol? , 2003, The Lancet.
[63] Sander Greenland,et al. Case–Control Studies , 2008 .
[64] H. Cooke,et al. Construction of human artificial chromosome vectors by recombineering. , 2005, Gene.
[65] A. Folsom,et al. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.
[66] G. Taubes. Epidemiology faces its limits. , 1995, Science.
[67] T. Dawber,et al. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. , 1980, Survey of ophthalmology.
[68] Elio Riboli,et al. The EPIC Project: Rationale and study design , 1997 .
[69] Timothy B. Stockwell,et al. The Sequence of the Human Genome , 2001, Science.
[70] Junjun Zhang,et al. Hotspots for copy number variation in chimpanzees and humans. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[71] P. Albert,et al. Models for longitudinal data: a generalized estimating equation approach. , 1988, Biometrics.
[72] B Langholz,et al. Cohort studies for characterizing measured genes. , 1999, Journal of the National Cancer Institute. Monographs.
[73] E. Tai,et al. Dietary fat interacts with the -514C>T polymorphism in the hepatic lipase gene promoter on plasma lipid profiles in a multiethnic Asian population: the 1998 Singapore National Health Survey. , 2003, The Journal of nutrition.
[74] E. Boerwinkle,et al. Factor XIIIA Val34Leu Polymorphism Does Not Predict Risk of Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.